FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Real-time BOERSE MUENCHEN 01:15:23 25/05/2024 am IST | ||
| 7.2 EUR | -1.91% |
|
| Current month | -0.27% | ||
| 1 month | +61.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 25/24/25 | 7.2 | -1.91% |
| 23/24/23 | 7.34 | -16.11% |
| 22/24/22 | 8.75 | -3.42% |
| 21/24/21 | 9.06 | -7.93% |
| 20/24/20 | 9.84 | +2.50% |
Real-time BOERSE MUENCHEN
Last update May 25, 2024 at 01:15 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD36BX |
| ISIN | DE000HD36BX8 |
| Date issued | 28/02/2024 |
| Strike | 174.5 $ |
| Maturity | Unlimited |
| Parity | 6.06 : 1 |
| Emission price | 10.73 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.51 € |
|---|---|
| Lowest since issue | 4.19 € |
| Spread | 0.04 € |
| Spread % | 0.55% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
218.1
USD
Average target price
286.1
USD
Spread / Average Target
+31.18%
- Stock Market
- Certificates
- Certificat
